9 Reasons to Buy Pfizer in 2018 and 1 Big One Not To Post author:Sam Post published:December 21, 2017 Post category:BioPharma Pfizer may be the surprise strong-growth stock for next year. Source: BioSpace You Might Also Like St. Jude Medical Settles Lawsuit Over CRM Leads for $39 Million July 8, 2016 Regeneron Forges Out-of-the-Box R&D Pact With Boston's Decibel Therapeutics November 28, 2017 Roche Faces Off With Itself for $9 Billion Breast Cancer Drug Business February 13, 2017
